Susann Schonefeldt
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib.
Journal: HemaSphere
Published: October 27, 2025
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.
Journal: Leukemia
Published: January 10, 2025
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Journal: The Journal of clinical investigation
Published: January 04, 2023
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 16, 2022
The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.
Journal: Cancers
Published: October 01, 2021
Cytotoxic T-lymphocyte-associated protein 4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky severe combined immunodeficiency.
Journal: The Journal of allergy and clinical immunology
Published: June 15, 2016
Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes.
Journal: Nature genetics
Published: December 28, 2015
IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
Journal: The Journal of allergy and clinical immunology
Published: August 20, 2015
C-kit is important for SOD1(G93A) mouse survival independent of mast cells.
Journal: Neuroscience
Published: February 14, 2015
Transcriptional upregulation of myelin components in spontaneous myelin basic protein-deficient mice.
Journal: Brain research
Published: December 17, 2014
Type 1 diabetes in NOD mice unaffected by mast cell deficiency.
Journal: Diabetes
Published: June 12, 2014
Last Updated: 09/26/2026